首页> 外国专利> Inhibitor compostion for TLR4-MD2 comprising fraction of ethanol extract of Hibiscus Syriacus

Inhibitor compostion for TLR4-MD2 comprising fraction of ethanol extract of Hibiscus Syriacus

机译:用于TLR4-MD2的抑制剂组合物,其包含苜蓿乙醇提取物的乙醇提取物

摘要

In the present invention, a fraction of the ethanol extract of Mugunghwa or a flavonoid compound isolated therefrom binds to TLR4-MD, inhibits the activity of TLR4-MD, inhibits the activation of TLR4-MD induced by LPS, and inhibits and prevents the inflammatory reaction. . Specifically, it inhibited the production of NO induced by LPS, effectively inhibited the expression of iNOS and COX-2 proteins and pro-inflammatory cytokines TNF-α, IL-6, and IL-12, and the survival rate of the sepsis zebrafish model and It was confirmed that it has an anti-inflammatory effect by reducing teratogenicity. Therefore, the fraction of the ethanol extract of Mugunghwa can be used for prevention, improvement or treatment of inflammatory diseases or/and for alleviating skin inflammation.
机译:在本发明中,穆丘(其中类乙醇提取物的一部分或从其分离的黄酮化合物与TLR4-MD结合,抑制TLR4-MD的活性,抑制LPS诱导的TLR4-MD的活化,并抑制并抑制炎症反应。 。具体而言,它抑制了LPS诱导的产生,有效地抑制了INOS和COX-2蛋白和促炎细胞因子TNF-α,IL-6和IL-12的表达,以及脓毒症斑马鱼模型的存活率并且证实它通过减少致畸性而具有抗炎作用。因此,Mugunghwa的乙醇提取物的分数可用于预防,改善或治疗炎性疾病或/和缓解皮肤炎症。

著录项

  • 公开/公告号KR20210041401A

    专利类型

  • 公开/公告日2021-04-15

    原文格式PDF

  • 申请/专利权人 제주대학교 산학협력단;

    申请/专利号KR1020190124084

  • 发明设计人 김기영;

    申请日2019-10-07

  • 分类号A61K36/185;A23L33/105;A61K31/7048;A61K8/60;A61K8/9789;A61P29;A61Q19;

  • 国家 KR

  • 入库时间 2022-08-24 18:15:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号